Package Leaflet:Information for the User
Atomoxetine Macleods 10, 18, 25, 40, 60, 80 and 100 mg hard capsules EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What it is used for
Atomoxetine Macleods contains atomoxetine and is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in:
It is used as part of a comprehensive treatment programme, which includes psychological, educational, and social measures.
It is not intended for use in children under 6 years of age, as the safety and efficacy in this age group have not been established.
In adults, Atomoxetine Macleods is used to treat ADHD when the symptoms are very troublesome and affect work or social life and when symptoms of ADHD have been present since childhood.
How it works
Atomoxetine Macleods increases the levels of noradrenaline in the brain. This is a chemical that is produced naturally and increases attention and decreases impulsiveness and hyperactivity in patients with ADHD. This medicine has been prescribed to help control the symptoms of ADHD. This medicine is not a stimulant and does not have the same effects as stimulants.
It may take a few weeks for Atomoxetine Macleods to start working.
About ADHD
Children and adolescents with ADHD find it very hard to:
This is not because they are not trying, but because their brains are not working in the same way as other people's. Many children and adolescents with ADHD find it very hard to make friends and may feel lonely. Adults with ADHD find it hard to do all the things that children with ADHD find hard. This can cause problems at work, at home, and with their friends and family.
Adults with ADHD may also have problems such as:
Do not takeAtomoxetine Macleodsif you:
Do not take Atomoxetine Macleods if any of the above apply to you. If you are not sure, consult your doctor or pharmacist before taking Atomoxetine Macleods, as it may worsen these conditions.
Warnings and precautions
Serotonin syndrome
Serotonin syndrome is a potentially life-threatening condition that may occur when taking Atomoxetine Macleods with other medicines (see section 2 "Other medicines and Atomoxetine Macleods"). The signs and symptoms of serotonin syndrome can include a combination of the following: confusion, restlessness, lack of coordination, and rigidity, hallucinations, coma, rapid heartbeat, increased body temperature, changes in blood pressure, sweating, flushing, tremors, hyperactive reflexes, nausea, vomiting, and diarrhea. Contact a doctor or go to the emergency department of the nearest hospital immediately if you think you are experiencing serotonin syndrome.
Both adults and children should be aware of the following warnings and precautions. Consult your doctor or pharmacist before starting treatment with Atomoxetine Macleods if you have:
a history of epilepsy or have had seizures for any other reason. Atomoxetine Macleods may increase the frequency of seizures.
Treatment with Atomoxetine Macleods may make you feel aggressive, hostile, or violent, or make these symptoms worse if they were already present before treatment. It may also cause unusual changes in your behaviour or mood (including physical aggression, threatening behaviour, and thoughts of harming others). If you or your family and/or friends notice any of these reactions, talk to your doctor or pharmacist immediately.
Consult your doctor or pharmacist if you have any of the symptoms mentioned above before starting treatment, as Atomoxetine Macleods may make these problems worse. Your doctor will want to monitor how the medicine affects you.
Tests your doctor will do before you start takingAtomoxetine Macleods
These tests are to decide if Atomoxetine Macleods is the right medicine for you.
Your doctor will:
Your doctor will ask you about:
It is very important that you provide all the information you can. This will help your doctor decide if Atomoxetine Macleods is the right medicine for you. Your doctor may decide to do other medical tests before starting treatment with this medicine.
TakingAtomoxetine Macleodswith other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes medicines that you buy without a prescription. Your doctor will decide if you can take Atomoxetine Macleods with other medicines and may need to adjust the dose or increase it more slowly.
Do not take Atomoxetine Macleods with medicines called MAOIs (monoamine oxidase inhibitors) taken for depression. See section 2 "Do not take Atomoxetine Macleods".
If you are taking other medicines, Atomoxetine Macleods may affect how they work or cause side effects. If you are taking any of the following medicines, check with your doctor or pharmacist before taking Atomoxetine Macleods:
The following medicines may increase the risk of an abnormal heart rhythm when taken with Atomoxetine Macleods:
If you are not sure if the medicines you are taking are listed above, consult your doctor or pharmacist before taking Atomoxetine Macleods.
Atomoxetine Macleods may affect or be affected by other medicines. These include:
Pregnancy, breast-feeding and fertility
It is not known if this medicine can affect the unborn baby or pass into breast milk.
If you:
consult your doctor or pharmacist before taking this medicine.
Driving and using machines
Atomoxetine Macleods may cause drowsiness, dizziness, or affect your ability to concentrate and make decisions. Be careful while driving or operating machinery until you know how Atomoxetine Macleods affects you. If you feel drowsy, dizzy, or have difficulty concentrating, you should not drive or operate machinery.
Important information about some of the ingredients ofAtomoxetine Macleods
Do not open Atomoxetine Macleods capsules, as the contents may irritate your eyes. If the contents of the capsules come into contact with your eyes, rinse them immediately with plenty of water and consult your doctor. If your hands or any other part of your body come into contact with the contents of the capsule, wash the area with water as soon as possible.
How much to take
If you are a child (over 6 years) or adolescent:
Your doctor will tell you how much Atomoxetine Macleods to take, based on your weight. You will usually start with a low dose before increasing it, based on your weight.
Adults
If you have liver problems, your doctor may recommend a lower dose.
If you take moreAtomoxetine Macleodsthan you should
If you have taken too much Atomoxetine Macleods, contact your doctor or pharmacist immediately or go to the emergency department of the nearest hospital. The most commonly reported symptoms of overdose are gastrointestinal symptoms, drowsiness, dizziness, tremors, and abnormal behaviour. Very rarely, serotonin syndrome, a potentially life-threatening condition, has also been reported. (See section 2, Warnings and precautions, Serotonin syndrome).
If you forget to takeAtomoxetine Macleods
If you forget to take a dose, take another as soon as you remember, but do not take more than the total daily dose in a 24-hour period. Do not take a double dose to make up for a forgotten dose.
If you stop takingAtomoxetine Macleods
If you stop taking Atomoxetine Macleods, you may not experience any side effects, but your ADHD symptoms may return. You should talk to your doctor before stopping treatment.
What your doctor will do while you are takingAtomoxetine Macleods
Your doctor will do some tests
Tests will also be done when the dose is changed. These tests will include:
Long-term treatment
Atomoxetine Macleods does not need to be taken indefinitely. If you take Atomoxetine Macleods for more than a year, your doctor will review your treatment to see if the medicine is still needed.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Although some people suffer from adverse effects, most people consider that Atomoxetina Macleods helps them. Your doctor will talk to you about these adverse effects.
Some adverse effects could be serious. If you experience any of the following effects, contact your doctor immediately.
Uncommon(may affect up to 1 in 100 people)
Children and young people under 18 years of age are at greater risk of suffering from adverse effects such as:
Adults have a lower risk(may affect up to 1 in 1,000 people) of suffering from adverse effects such as:
Rare(may affect up to 1 in 1,000 people)
Stop treatment with Atomoxetina Macleods and contact your doctor immediately if you experience any of the following adverse effects:
Other reported adverse effects are as follows. If any of them worsen, consult your doctor or pharmacist.
Adverse effects very common(may affect more than 1 in 10 people) | |
CHILDREN over 6 years and YOUNG PEOPLE | ADULTS |
These effects may disappear over time in most patients |
|
Adverse effects common(may affect up to 1 in 10 people) | |
CHILDREN over 6 years and YOUNG PEOPLE | ADULTS |
|
|
Adverse effects uncommon(may affect up to 1 in 100 people) | |
CHILDREN over 6 years and YOUNG PEOPLE | ADULTS |
|
|
Adverse effects rare(may affect up to 1 in 1,000 people) | |
CHILDREN and YOUNG PEOPLE over 6 years | ADULTS |
|
|
Only in pediatric patients:
Involuntary grinding of the teeth (bruxism). (Frequency not known).
Effects on growth
When some children start taking Atomoxetina Macleods, their growth (weight and height) is reduced. However, with long-term treatment, children recover the weight and height appropriate for their age group.
Your doctor will monitor your child's height and weight. If your child is not growing or gaining weight as expected, your doctor may change the dose or temporarily suspend treatment with Atomoxetina Macleods.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and blister after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines that you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition of Atomoxetina Macleods hard capsules 10, 18, 25, 40, 60, 80, and 100 mg.
Yellow iron oxide (E172) (18 mg, 60 mg, 80 mg, and 100 mg)
Titanium dioxide (E171) (10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, and 100 mg)
FD&C blue 2 (carmine indigo) (E132) (25 mg, 40 mg, and 60 mg)
Red iron oxide (E172) (80 mg and 100 mg)
Printing ink
Shellac (E904), Dehydrated alcohol (E1510), Isopropyl alcohol, Butanol, Propylene glycol (E1520), Ammonium hydroxide (E527), Black iron oxide (E172), Potassium hydroxide (E525)
Appearance of the product and package contents
10 mg: Size "3" capsule with white opaque cap/white opaque body, contains a white to off-white powder, with "I 23" printed in black ink on the body.
18 mg: Size "3" capsule with golden cap/white opaque body, contains a white to off-white powder, with "I 24" printed in black ink on the body.
25 mg: Size "3" capsule with blue opaque cap/white opaque body, contains a white to off-white powder, with "I 25" printed in black ink on the body.
40 mg: Size "3" capsule with blue opaque cap/blue opaque body, contains a white to off-white powder, with "I 26" printed in black ink on the body.
60 mg: Size "2" capsule with blue opaque cap/golden body, contains a white to off-white powder, with "I 27" printed in black ink on the body.
80 mg: Size "2" capsule with brown opaque cap/white opaque body, contains a white to off-white powder, with "I 28" printed in black ink on the body.
100 mg: Size "1" capsule with brown opaque cap/brown opaque body, contains a white to off-white powder, with "I 29" printed in black ink on the body.
The capsules are packaged in clear PVC/PVdC blister packs - Aluminum
Package sizes: 7, 28, and 56 capsules.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Macleods Pharma España S.L.U.
Avenida Diagonal, 468, 6º, puerta A
08006 Barcelona
Spain
Manufacturer
Synoptis Industrial Sp. z o.o
ul. Rabowicka 15, 62-020
Swarzedz, Poland
Fairmed Healthcare GmbH
Maria-Goeppert-Straße 3
23562 Lübeck
Germany
Macleods Pharma UK Limited
Wynyard Park House,
Wynyard Avenue, Wynyard,
Billingham, TS22 5TB
United Kingdom
Date of the last revision of this prospectus:November 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)